Clinical Trial Update: Peginterferon Plus Ribavirin for Hepatitis C Patients Concomitant With Malignancy Other Than Hepatocellular Carcinoma [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating pegylated interferon plus ribavirin in chronic hepatitis C patients with other malignancies (not hepatocellular carcinoma) has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C
• Neoplasms

Drugs mentioned

• Pegasys (peginterferon alfa-2a) (peginterferon alfa-2a)
• Ribavirin (ribavirin)

Snippet

Sponsor: Kaohsiung Medical University Chung-Ho Memorial Hospital | Conditions: Chronic Hepatitis C, Neoplasms | Phase 4 | Status: COMPLETED